FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds with common formulae I, II, IV and V: (I), (III), (IV), (V), values of radicals, such as provided in invention formula. Besides, proposed invention relates to pharmaceutical composition on the basis of above-described compounds, to their application, and also to method for treatment of repeated urination, incontinence and higher activity of urinary bladder, besides, to method to treat pain.
EFFECT: new compounds have been produced and described, which may be useful for treatment of diseases related to fatty-acid amide-hydrolase (FAAH), in particular to treat repeated urination and incontinence, higher activity of bladder and/or pain.
16 cl, 442 ex, 73 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDYL NONAROMATIC NITROGEN-CONTAINING HETEROCYCLO-1-CARBOXYLATE DERIVATIVE | 2006 |
|
RU2408581C2 |
CONDENSING DICYCLIC NITROGEN CONTAINING HETEROCYCLES, WHICH HAVE DGAT INHIBITING ACTION | 2003 |
|
RU2342388C2 |
ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
AZOLE COMPOUNDS | 2009 |
|
RU2493154C2 |
C-FMC KINASE INHIBITORS | 2007 |
|
RU2475483C2 |
METHOD OF OBTAINING DERIVATIVES OF 7-(HETERO)ARYL-4,5,6,7-TETRAHYDRO[1,2,3]TRIAZOLO[1,5-A]PYRIDINE | 2013 |
|
RU2563254C2 |
BENZYLAMINE DERIVATIVES | 2014 |
|
RU2660421C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2005 |
|
RU2389731C2 |
HISTONE DEACETYLASE INHIBITORS | 2014 |
|
RU2673819C2 |
Authors
Dates
2011-01-10—Published
2006-02-16—Filed